High-throughput screening protocol created to discover SHP2 inhibitors
Researchers have developed a cross-validation high-throughput screening method to accelerate the identification of SHP2 inhibitors.
List view / Grid view
Researchers have developed a cross-validation high-throughput screening method to accelerate the identification of SHP2 inhibitors.
This article highlights some of the most recent drug target discoveries that could be used to develop and design a treatment for pancreatic cancer.
A study has demonstrated that a novel vaccine design for pancreatic cancer has been successful in mice, doubling survival time.
Researchers have found a specific strain of Helicobacter pylori strongly correlated with stomach cancer...